Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).

Miguel Angel Villalona-Calero; John Paul Diaz; Zuanel Diaz; Wenrui Duan; Eric Douglas Schroeder; Santiago Aparo; Troy Antony Gatcliffe; Alfredo Pedro Alonso; Sebastian Cuitiva; Federico Albrecht; Siddhartha A. Venkatappa; Victor Guardiola; Michael B. Troner; Sara M. Garrido; Gail Walker; Muni Rubens; Fernando I. De Zarraga; Hao Vuong

doi:10.1200/jco.2019.37.15_suppl.2555

Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).

Miguel Angel Villalona-Calero, John Paul Diaz, Zuanel Diaz, Wenrui Duan, Eric Douglas Schroeder, Santiago Aparo, Troy Antony Gatcliffe, Alfredo Pedro Alonso, Sebastian Cuitiva, Federico Albrecht, Siddhartha A. Venkatappa, Victor Guardiola, Michael B. Troner, Sara M. Garrido, Gail Walker, Muni Rubens, Fernando I. De Zarraga, Hao Vuong

Research output: Contribution to conference › Presentation

Original language	American English
DOIs	https://doi.org/10.1200/jco.2019.37.15_suppl.2555
State	Published - May 20 2019
Event	Journal of Clinical Oncology - Duration: Jan 1 2020 → …

Conference

Conference	Journal of Clinical Oncology
Period	1/1/20 → …

Disciplines

Oncology
Pathology
Medicine and Health Sciences

Access to Document

10.1200/jco.2019.37.15_suppl.2555License: Unspecified

Cite this

Villalona-Calero, M. A., Diaz, J. P., Diaz, Z., Duan, W., Schroeder, E. D., Aparo, S., Gatcliffe, T. A., Alonso, A. P., Cuitiva, S., Albrecht, F., Venkatappa, S. A., Guardiola, V., Troner, M. B., Garrido, S. M., Walker, G., Rubens, M., De Zarraga, F. I., & Vuong, H. (2019). Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2019.37.15_suppl.2555

Villalona-Calero, MA, Diaz, JP , Diaz, Z, Duan, W, Schroeder, ED, Aparo, S, Gatcliffe, TA, Alonso, AP, Cuitiva, S, Albrecht, F , Venkatappa, SA, Guardiola, V, Troner, MB, Garrido, SM, Walker, G, Rubens, M, De Zarraga, FI & Vuong, H 2019, 'Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).', Journal of Clinical Oncology, 1/1/20. https://doi.org/10.1200/jco.2019.37.15_suppl.2555

@conference{78e258a078ee4df99bf53a2befa0b510,

title = "Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).",

author = "Villalona-Calero, {Miguel Angel} and Diaz, {John Paul} and Zuanel Diaz and Wenrui Duan and Schroeder, {Eric Douglas} and Santiago Aparo and Gatcliffe, {Troy Antony} and Alonso, {Alfredo Pedro} and Sebastian Cuitiva and Federico Albrecht and Venkatappa, {Siddhartha A.} and Victor Guardiola and Troner, {Michael B.} and Garrido, {Sara M.} and Gail Walker and Muni Rubens and {De Zarraga}, {Fernando I.} and Hao Vuong",

year = "2019",

month = may,

day = "20",

doi = "10.1200/jco.2019.37.15_suppl.2555",

language = "American English",

note = "Journal of Clinical Oncology ; Conference date: 01-01-2020",

}

TY - CONF

T1 - Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).

AU - Villalona-Calero, Miguel Angel

AU - Diaz, John Paul

AU - Diaz, Zuanel

AU - Duan, Wenrui

AU - Schroeder, Eric Douglas

AU - Aparo, Santiago

AU - Gatcliffe, Troy Antony

AU - Alonso, Alfredo Pedro

AU - Cuitiva, Sebastian

AU - Albrecht, Federico

AU - Venkatappa, Siddhartha A.

AU - Guardiola, Victor

AU - Troner, Michael B.

AU - Garrido, Sara M.

AU - Walker, Gail

AU - Rubens, Muni

AU - De Zarraga, Fernando I.

AU - Vuong, Hao

PY - 2019/5/20

Y1 - 2019/5/20

UR - https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.2555

U2 - 10.1200/jco.2019.37.15_suppl.2555

DO - 10.1200/jco.2019.37.15_suppl.2555

M3 - Presentation

T2 - Journal of Clinical Oncology

Y2 - 1 January 2020

ER -

Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).

Conference

Disciplines

Access to Document

Other files and links

Cite this